Citation Impact
Citing Papers
Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors
2014
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
2015 StandoutNobel
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Randomized Trial of Radiation Therapy Plus Procarbazine, Lomustine, and Vincristine Chemotherapy for Supratentorial Adult Low-Grade Glioma: Initial Results of RTOG 9802
2012
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
2012
Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402
2006
Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH
2014
The role of telehealth during COVID-19 outbreak: a systematic review based on current evidence
2020 Standout
Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
2013
Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
2007
High levels of untreated distress and fatigue in cancer patients
2004 Standout
Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis
2002
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Nasopharyngeal carcinoma
2005 Standout
Positron emission tomography11C-methionine and survival in patients with low-grade gliomas
2001
The management of respiratory motion in radiation oncology report of AAPM Task Group 76a)
2006 Standout
Intra- and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning
1998
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
A general methodology for three‐dimensional analysis of variation in target volume delineation
1999
The future of high-grade glioma: Where we are and where are we going
2015
Advances in Radiation Therapy for Brain Tumors
2007
A survey of MRI-based medical image analysis for brain tumor studies
2013 Standout
Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma
2003
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
NOA‐03 trial of high‐dose methotrexate in primary central nervous system lymphoma: Final report
2005
Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline
2016
Invariant natural killer T cells are preserved in patients with glioma and exhibit antitumor lytic activity following dendritic cell‐mediated expansion
2004 StandoutNobel
Oligodendroglioma: An Appraisal of Recent Data Pertaining to Diagnosis and Treatment
1999
Glioblastoma and Other Malignant Gliomas
2013 Standout
Long‐term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma
2009
Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial
2005
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131
2015
American Association of Physicists in Medicine Radiation Therapy Committee Task Group 53: Quality assurance for clinical radiotherapy treatment planning
1998
Cancer immunotherapy via dendritic cells
2012 Standout
Survival rates in patients with low‐grade glioma after intraoperative magnetic resonance image guidance
2005
A 31-Year-Old Woman With a Transformed Low-grade Glioma
2010
Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time
2018
Trial watch
2013
Incidence of and survival from oligodendroglioma in Denmark, 1943–2002
2008
Large deformation three-dimensional image registration in image-guided radiation therapy
2005
EXTENT OF SURGICAL RESECTION IS INDEPENDENTLY ASSOCIATED WITH SURVIVAL IN PATIENTS WITH HEMISPHERIC INFILTRATING LOW-GRADE GLIOMAS
2008
COVID-19: Global radiation oncology’s targeted response for pandemic preparedness
2020
Conformity index: A review
2006 Standout
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Is there a role for parenteral nutrition or hydration at the end of life?
2012
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
Plant-based anticancer molecules: A chemical and biological profile of some important leads
2005
Human glioblastoma tumours and neural cancer stem cells express the chemokine CX3CL1 and its receptor CX3CR1
2010
Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis
1999
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome
2001
Guidelines on management of low‐grade gliomas: report of an EFNS–EANO* Task Force
2010
Radiation Dose–Volume Effects in the Brain
2010
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Advances in the molecular genetics of gliomas — implications for classification and therapy
2016
Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists
2002
The Role of Surgery in Low Grade Gliomas
1999
High-tech in radiation oncology: should there be a ceiling?
2004
Automatic segmentation, internal classification, and follow-up of optic pathway gliomas in MRI
2011
Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas
2010
BRACHYTHERAPY FOR BRAIN TUMOR
1999
Anaplastic Oligodendroglioma and Oligoastrocytoma
2007
Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer
1999
Variability in target volume delineation on CT scans of the breast
2001
Brain tumor target volume determination for radiation treatment planning through automated MRI segmentation
2004
Malignant Gliomas in Adults
2008 Standout
Maximizing safe resection of low- and high-grade glioma
2016
Brain tumor segmentation with Deep Neural Networks
2016 Standout
Pitfalls in the diagnosis of brain tumours
2006
Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas1
2006
elastix: A Toolbox for Intensity-Based Medical Image Registration
2009 Standout
Clinical Evaluation of a Fully-automatic Segmentation Method for Longitudinal Brain Tumor Volumetry
2016
Definition of gross tumor volume in lung cancer: inter-observer variability
2002
The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy
2000 Standout
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Primary brain tumours in adults
2012 Standout
Radiation Dose–Volume Effects in the Heart
2010
Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations
2004 Standout
Neurocognitive and Functional Assessment of Patients With Brain Metastases
2003
Survey of treatment recommendations for anaplastic oligodendroglioma
2007
Comparison of a Strategy Favoring Early Surgical Resection vs a Strategy Favoring Watchful Waiting in Low-Grade Gliomas
2012
Camptothecin: current perspectives
2004
Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18 FDG-hybrid PET fusion
2001
High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
2009 Standout
Delayed Neurotoxicity in Primary Central Nervous System Lymphoma
2005
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
2011
Variability of Target and Normal Structure Delineation for Breast Cancer Radiotherapy: An RTOG Multi-Institutional and Multiobserver Study
2009
Brain Tumors
2001 Standout
IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma
2011
Bevacizumab and daily temozolomide for recurrent glioblastoma
2011
Y a-t-il des limites physiques, techniques et morphologiques à la radiothérapie conformationnelle?
2001
Gallic acid: a versatile antioxidant with promising therapeutic and industrial applications
2015 Standout
Primary CNS Lymphoma in Immunocompetent Patients
2009
Management of glioblastoma: State of the art and future directions
2020 Standout
Correlations Between O6-Methylguanine DNA Methyltransferase Promoter Methylation Status, 1p and 19q Deletions, and Response to Temozolomide in Anaplastic and Recurrent Oligodendroglioma: A Prospective GICNO Study
2006
Mismatch Repair Deficiency Does Not Mediate Clinical Resistance to Temozolomide in Malignant Glioma
2008 StandoutNobel
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
2004 Standout
Phase II Study of Imatinib in Patients With Recurrent Gliomas of Various Histologies: A European Organisation for Research and Treatment of Cancer Brain Tumor Group Study
2008
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
The epidemiology of glioma in adults: a "state of the science" review
2014 Standout
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases
2016 Standout
Recent synthetic developments in a powerful imino Diels–Alder reaction (Povarov reaction): application to the synthesis of N-polyheterocycles and related alkaloids
2008 Standout
Phase II Trial of Procarbazine, Lomustine, and Vincristine as Initial Therapy for Patients With Low-Grade Oligodendroglioma or Oligoastrocytoma: Efficacy and Associations With Chromosomal Abnormalities
2003
Artificial intelligence in cancer imaging: Clinical challenges and applications
2019 Standout
Benefit of Temozolomide Compared to Procarbazine in Treatment of Glioblastoma Multiforme at First Relapse: Effect on Neurological Functioning, Performance Status, and Health Related Quality of Life
2005
Blood-Brain Barrier Disruption and Intra-Arterial Methotrexate-Based Therapy for Newly Diagnosed Primary CNS Lymphoma: A Multi-Institutional Experience
2009
Long-term outcome of low-grade oligodendroglioma and mixed glioma
2000
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
2019 Standout
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
2001 Standout
Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas
2008
La radiothérapie conformationnelle est-elle un progrès? Quelles en sont les difficultés et les limites?
2001
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
2008
Computerized Quality-of-Life Screening in a Cancer Pain Clinic
2001
Prospective Randomized Trial of Low- Versus High-Dose Radiation Therapy in Adults With Supratentorial Low-Grade Glioma: Initial Report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group Study
2002
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Brain Tumor Segmentation Using Convolutional Neural Networks in MRI Images
2016 Standout
Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma
2002
Macrophage plasticity and polarization in tissue repair and remodelling
2012 Standout
Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
2008
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
2010 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Phase II Trial of Temozolomide in Patients With Progressive Low-Grade Glioma
2003
Temozolomide As Initial Treatment for Adults With Low-Grade Oligodendrogliomas or Oligoastrocytomas and Correlation With Chromosome 1p Deletions
2004
Effects of Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma Measured by the Folstein Mini-Mental State Examination
2003
An extent of resection threshold for newly diagnosed glioblastomas
2011 Standout
Review on Quality of Life Issues in Patients with Primary Brain Tumors
2010
Works of Johan Menten being referenced
Interobserver variations in gross tumor volume delineation of brain tumors on CT and impact of MRI
1998
A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) study 22844
1996
Quality assessment of medical decision making in radiation oncology: variability in target volume delineation for brain tumours
1993
Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised Phase III trial on dose response (EORTC trial 22844)
1998
MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma
2008
Multicentre phase II and pharmacokinetic study of RFS2000 (9-nitro-camptothecin) administered orally 5 days a week in patients with glioblastoma multiforme
2002
A Multicenter Cohort Study of Dose-Dense Temozolomide (21 of 28 Days) for the Treatment of Recurrent Anaplastic Astrocytoma or Oligoastrocytoma
2008
Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
2012
Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value
2004
Palliative inpatients in general hospitals: a one day observational study in Belgium
2011
Accelerated radiotherapy in glioblastoma multiforme: a dose searching prospective study
1994
Interobserver variations in gross tumor volume delineation of brain tumors on computed tomography and impact of magnetic resonance imaging
2001
Salvage PCV chemotherapy for temozolomide-resistant oligodendrogliomas
2004
Cognitive status and quality of life after treatment for primary CNS lymphoma
2004
A phase III randomized controlled trial of short-course radiotherapy with or without concomitant and adjuvant temozolomide in elderly patients with glioblastoma (CCTG CE.6, EORTC 26062-22061, TROG 08.02, NCT00482677).
2016
A phase III randomized controlled trial of short-course radiotherapy with or without concomitant and adjuvant temozolomide in elderly patients with glioblastoma (CCTG CE.6, EORTC 26062-22061, TROG 08.02, NCT00482677).
2016
Phase II Study of First-Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors: The European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971
2003